# Cambrian Genomics, Inc. — Form D

Cambrian Genomics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-11-20. The offering totals $10.5M, of which $10.0M was reported sold. Industry: Other.

## Offering

- Filed: 2014-11-20
- Form: D
- Accession: 0001625520-14-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $10.5M
- Amount sold: $10.0M
- Remaining: $484K
- Minimum investment: $1
- Investors: 105
- Date of first sale: 2014-11-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-228731

## Issuer

- Name: Cambrian Genomics, Inc.
- CIK: 0001625520
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 665 3RD STREET, SUITE 425, SAN FRANCISCO, CA, 94107
- Phone: 619-861-6156

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Reese Jones | Director | Houston, TX |
| Austen Heinz | Director | San Francisco, CA |
| Austen Heinz | Executive Officer | San Francisco, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2014-12-19](https://search.stillhousedata.com/formd/0001625520-14-000002) | D/A | $12.5M | $11.2M |

## More

- [CIK 1625520 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1625520&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001625520-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.